ArticleTechnology in cancer research & treatment
Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle-Related Pathways.
Jiayuan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.